Elsevier

Steroids

Volume 56, Issue 10, October 1991, Pages 518-523
Steroids

Glucocorticoid-induced osteoporosis: a cross-sectional study

https://doi.org/10.1016/0039-128X(91)90117-EGet rights and content

Abstract

We studied 70 patients (48 women and 22 men) with either rheumatic disease (n = 25) or lung disease (n = 45) who had been treated with glucocorticoids for at least 6 months (mean cumulative dose, 24.2 ± 27.1 g of prednisone; mean current dose, 11.0 ± 8.6 mg/d, mean duration of therapy, 8.1 years. We measured bone mineral density (BMD) of the hip (femoral neck) and spine (L2-L4) using dualphoton absorptiometry and BMD of the distal one third radius using single-photon absorptiometry. Compared with age-matched controls, the study population had decreased BMD of the spine (87.0%), hip (87.2%), and radius (90.6%). Current dose, cumulative dose, and duration of therapy were not correlated with BMD in the spine or hip in the total study population. The most significant correlations with low bone mass at the hip and spine were short height and low weight. There was a high incidence of hypercalciuria (30%) as compared with an age- and sex-matched control group (6.4%). Glucocorticoids are known to decrease vertebral and radial bone density. We conclude that glucocorticoids also decrease hip bone density as measured at the femoral neck. The high incidence of hypercalciuria may have implications for therapy of glucocorticoid-induced osteoporosis.

References (25)

  • OS Als et al.

    Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis?

    Ann Rheum Dis

    (1985)
  • TR Dykman et al.

    Evaluation of factors associated with glucocorticoidinduced osteopenia in patients with rheumatic diseases

    Arthritis Rheum

    (1985)
  • Cited by (25)

    • Imaging of Osteoporosis

      2013, Osteoporosis: Fourth Edition
    • Imaging of Metabolic Bone Diseases

      2008, Radiologic Clinics of North America
      Citation Excerpt :

      Brown tumors often may occur; they present as focal osteolitic areas with swelling of bone most localized at ribs and long bones of hand and foot. Hypercortisolism probably is the most common cause of medication-induced generalized osteoporosis, whereas the endogenous form, Cushing's disease, is rare.135,136 Decreased bone formation and increased bone resorption are observed in hypercortisolism.

    • Osteoporosis in steroid-dependent asthma

      1996, Annals of Allergy, Asthma and Immunology
    • Major adverse effects from systemic drugs: Defining the risks

      1995, Current Problems in Dermatology (United States)
    • Drug-induced bone disease

      1994, Clinics in Geriatric Medicine
    View all citing articles on Scopus
    View full text